A smaller fraction of glutamate is removed by the neuronal glutamate transporter, EAAC1/EAAT3
The Synergy Factor: Because their mechanisms are completely different (BPC-157 builds blood vessels
Other related diseases such as fontal temporal dementia (FTD) appears to have overlap both with AD and ALS, and is commonly related with TDP-43 and C9ORF72 mutations of ALS (Warren et al., 2013), although there is evidence for TDP-43 involvement in AD, it appears to take a different progression pattern compared to ALS and FTD (Meneses et al., 2021), which suggests distinct disease mechanisms at play
Multiply the vial size by the target volume, then divide by the desired dose
Each batch undergoes third-party testing for purity, identity, and heavy metals
Werner et al